Evaluating the cost-effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs-Reference-Cited by-同舟云学术

Evaluating the cost-effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs

Published:2019-01-23 Issue:3 Volume:114 Page:560-570
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Sweeney Sedona¹,Ward Zoe²^ORCID,Platt Lucy¹^ORCID,Guinness Lorna¹,Hickman Matthew²^ORCID,Hope Vivian³^ORCID,Maher Lisa⁴^ORCID,Iversen Jenny⁴,Hutchinson Sharon J.⁵,Smith Josie⁶,Ayres Rachel⁷,Hainey Ingrid⁸,Vickerman Peter²^ORCID

Affiliation:

1. Faculty of Public Health and Policy; London School of Hygiene and Tropical Medicine; London UK

2. Bristol Medical School, Population Health Sciences; University of Bristol; Bristol UK

3. Public Health Institute; Liverpool John Moores University; Liverpool UK

4. Kirby Institute for Infection and Immunity; UNSW; Sydney Australia

5. Glasgow Caledonian University, Glasgow, Scotland; UK

6. Public Health Wales; Cardiff Wales, UK CF10 4BZ

7. Bristol Drugs Project; Bristol UK

8. Cair Scotland; Dundee Scotland, UK

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/add.14519/fullpdf

Reference57 articles.

1. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence;Mohd Hanafiah;Hepatology,2013

2. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide;Perz;J Hepatol,2006

3. Public Health England Hepatitis C in the UK 2015 Report 2015

4. Public Health England People who Inject Drugs: HIV and Viral Hepatitis Unlinked Anonymous Monitoring Survey Tables (Pyschoactive): 2016 Update 2016

5. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013;Degenhardt;Lancet Infect Dis,2016

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimated Number of Injection-Involved Overdose Deaths in US States From 2000 to 2020: Secondary Analysis of Surveillance Data;JMIR Public Health and Surveillance;2024-04-05

2. “No-one just does drugs during business hours!”: evaluation of a 24/7 primary needle and syringe program in St Kilda, Australia;Harm Reduction Journal;2024-02-24

3. Scale-up of direct-acting antiviral treatment in prisons is both cost-effective and key to HCV elimination;Open Forum Infectious Diseases;2023-12-18

4. Prioritizing Harm Reduction Services to Reduce the Burden of Substance Use;Journal of Addictions Nursing;2023-10

5. Prioritizing harm reduction services to reduce the burden of substance use: A joint position statement of the International Society of Psychiatric Mental Health Nurses (ISPN) and the International Nurses Society on Addictions (IntNSA)-USA Chapter;Archives of Psychiatric Nursing;2023-06